Mantz, Constantine <br/><br/>
A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-Up.  [electronic resource] 

 -  Frontiers in oncology  2014 
 - 279 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2234-943X 
<br/><br/><label>Standard No.: </label>10.3389/fonc.2014.00279  doi